CCHT: Clinical trial application for GenSci143 injection has been accepted
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Changchun High-Tech announced that its subsidiary, Changchun JinSai Pharmaceutical Co., Ltd. ("JinSai Pharmaceutical"), has received written notification from the U.S. Food and Drug Administration ("FDA") that the clinical trial application for GenSci143 for injection has been accepted, with the indication being: advanced solid tumors
According to the Zhitong Finance APP, Changchun Gaoxin (000661.SZ) announced that its subsidiary, Changchun JinSai Pharmaceutical Co., Ltd. ("JinSai Pharmaceutical"), received a written notice from the U.S. Food and Drug Administration ("FDA") that the clinical trial application for GenSci143 for injection has been accepted, with the indication being: advanced solid tumors